Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03178578
Other study ID # LNR/17/Austin/94
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 18, 2017
Est. completion date January 2020

Study information

Verified date September 2019
Source Karolinska Institutet
Contact Maria Cronhjort, MD, PhD
Phone +466161000
Email maria.cronhjort@sll.se
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This prospective observational study aims to (i) asses intensive care doctors trigger for and the expected physiological response to a fluid bolus and (ii) evaluate the patient's actual physiological response to a single fluid bolus at one hour post-bolus for 100 adult patients admitted to the intensive care unit will be included in the study.


Description:

Intensive care unit patients often receive a fluid bolus during their ICU-stay. ICU doctors use a variety of clinical triggers when deciding whether or not to give a fluid bolus. However, the type of physiological triggers used and their correlation to the anticipated physiological response of the patient to an administered fluid bolus is not entirely clear.

The investigators will perform a prospective observational study to evaluate the triggers for, expected physiological and actual physiological response to fluid bolus therapy in the intensive care unit. Specifically, the investigators will assess which of the the physiological trigger(s) intensive care doctors use when deciding to give a fluid bolus; the expected physiological response to the fluid bolus by intensive care doctors; and, to what degree the patients actual physiological response 1 hour after a fluid bolus correlate with expectations.

This study will involve a survey of ICU physicians to determine the physiological trigger and expectations and a medical audit to ascertain the physiological response to a fluid bolus. The investigators will evaluate a single fluid bolus in 100 separate intensive care unit patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date January 2020
Est. primary completion date December 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients admitted to the intensive care unit and prescribed a fluid bolus.

Exclusion Criteria:

- The intensive care physician declines to participate.

- Expected survival < 24h

Study Design


Locations

Country Name City State
Australia Austin Hospital Melbourne Victoria
Sweden Danderyds sjukhus Stockholm Danderyd
Sweden Södersjukhuset Stockholm

Sponsors (3)

Lead Sponsor Collaborator
Karolinska Institutet Austin Hospital, Melbourne Australia, Danderyd Hospital

Countries where clinical trial is conducted

Australia,  Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of anticipated hemodynamic effects at completion of bolus The accuracy and precision between the expected and the observed physiological effects will be described using Bland-Altman methodology At completion of bolus
Secondary Accuracy of anticipated hemodynamic effects at one hour after completion of the fluid bolus The accuracy and precision between the expected and the observed physiological effects will be described using Bland-Altman methodology At one hour after completion of the fluid bolus
Secondary The hemodynamic effects of a fluid bolus at completion of bolus The effect of the fluid bolus on blood pressure at completion of bolus will be described. At completion of bolus
Secondary The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus The effect of the fluid bolus on blood pressure one hour after completion of the fluid bolus will be described. At one hour after completion of the fluid bolus
Secondary The hemodynamic effects of a fluid bolus at completion of bolus The effect of the fluid bolus on heart rate at completion of bolus will be described. At completion of bolus
Secondary The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus The effect of the fluid bolus on heart rate one hour after completion of the fluid bolus will be described. At one hour after completion of the fluid bolus
Secondary The hemodynamic effects of a fluid bolus at completion of bolus The effect of the fluid bolus on cardiac index at completion of bolus will be described. At completion of bolus
Secondary The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus The effect of the fluid bolus on cardiac index one hour after completion of the fluid bolus will be described. At one hour after completion of the fluid bolus
Secondary The hemodynamic effects of a fluid bolus at completion of bolus The effect of the fluid bolus on CVP at completion of bolus will be described. At completion of bolus
Secondary The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus The effect of the fluid bolus on CVP one hour after completion of the fluid bolus will be described. At one hour after completion of the fluid bolus
Secondary The hemodynamic effects of a fluid bolus at completion of bolus The effect of the fluid bolus on ScVO2 or SvO2 at completion of bolus will be described. At completion of bolus
Secondary The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus The effect of the fluid bolus on ScVO2 or SvO2 one hour after completion of the fluid bolus will be described. At one hour after completion of the fluid bolus
Secondary The hemodynamic effects of a fluid bolus at completion of bolus The effect of the fluid bolus on lactate levels at completion of bolus will be described. At completion of bolus
Secondary The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus The effect of the fluid bolus on lactate levels one hour after completion of the fluid bolus will be described. At one hour after completion of the fluid bolus
Secondary The hemodynamic effects of a fluid bolus at completion of bolus The effect of the fluid bolus on urine output at completion of bolus will be described. At completion of bolus
Secondary The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus The effect of the fluid bolus on urine output one hour after completion of the fluid bolus will be described. At one hour after completion of the fluid bolus
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Recruiting NCT05578196 - Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections. N/A
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3